The Alliance of M&A Advisors is proud to feature this list of experts of all types:
Andrew Merken is a partner in the Corporate and Venture Capital & Emerging Companies groups, as well as Co-Chair of the Securities and the Life Sciences groups. He represents early and late stage private and public companies, particularly high tech and life sciences/health care companies, in transactional, corporate finance and corporate governance matters, including formation, seed and venture stage financings, mergers & acquisitions, equity and compensation matters, stockholder disputes, contract negotiations, public offerings, SEC and stock exchange compliance, and securities transactions and disclosure issues. Andy also represents public companies and investment banks in public offerings, PIPE financings, shelf takedowns and mergers & acquisitions.
Andy represents investors in venture capital funds, private foundations, family offices and individual angel investors in raising capital and making portfolio company investments and research grants, and also in acquisitions and corporate governance matters related to their portfolio companies. Portfolio company investments by Andy’s clients are generally in software, healthcare, healthcare IT, biotech, medical device, and biopharmaceutical companies.
Additionally, Andy represents C-level executives in employment matters, including equity compensation